Odyssey; BenevolentAI: Odyssey Announces Agreement to Combine with BenevolentAI
BenevolentAI is a leading, clinical-stage AI drug discovery company that combines advanced AI and machine learning with cutting edge science to discover and develop novel and more effective
Source: finanznachrichten.de